Cargando…
Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial
BACKGROUND: Chronic subdural hematoma (CSDH) is a common disease that is more prevalent in older people. Surgical intervention is a safe treatment of choice. However, the recurrence rate is relatively high and the outcome is not always satisfactory among surgically treated patients. It is believed t...
Autores principales: | Jiang, Rongcai, Wang, Dong, Poon, Wai Sang, Lu, Yi Cheng, Li, Xin Gang, Zhao, Shi Guang, Wang, Ren Zhi, You, Chao, Yuan, Xian Rui, Zhang, Jian Min, Feng, Hua, Fei, Zhou, Yu, Xin Guang, Zhao, Yuan Li, Hu, Jin, Kang, De Zhi, Yu, Ru Tong, Gao, Guo Dong, De Zhu, Xi, Sun, Tao, Hao, Jie He, Liu, Xian Zhi, Su, Ning, Yue, Shu Yuan, Zhang, Jian Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652431/ https://www.ncbi.nlm.nih.gov/pubmed/26581842 http://dx.doi.org/10.1186/s13063-015-1045-y |
Ejemplares similares
-
Atorvastatin combined with dexamethasone in chronic subdural haematoma (ATOCH II): study protocol for a randomized controlled trial
por: Jiang, Rong Cai, et al.
Publicado: (2021) -
Atorvastatin combined with dexamethasone promote hematoma absorption in an optimized rat model of chronic subdural hematoma
por: Wang, Dong, et al.
Publicado: (2021) -
Role of Regulatory T cells in Atorvastatin Induced Absorption of Chronic Subdural Hematoma in Rats
por: Quan, Wei, et al.
Publicado: (2019) -
Atorvastatin combined with low-dose dexamethasone for vascular endothelial cell dysfunction induced by chronic subdural hematoma
por: Fan, Yue-Shan, et al.
Publicado: (2020) -
Risk Factors for Atorvastatin as a Monotherapy for Chronic Subdural Hematoma: A Retrospective Multifactor Analysis
por: Zhang, Xinjie, et al.
Publicado: (2021)